Article
Gelsolin regulates cisplatin sensitivity in human head-and-neck cancer.
International journal of cancer - 15 Dec 2014
Wang Pei-Wen, Abedini Mohammad R, Yang Li-Xing, Ding Ann-Ann, Figeys Daniel, Chang Jang-Yang, Tsang Benjamin K, Shieh Dar-Bin
Abstract excerpt
Chemoresistance is a major challenge in cancer therapy. Cisplatin is commonly used for chemotherapy in patients with head-and-neck cancer (HNC), but it increases control of the disease by only 10-15%. Downregulation of proapoptotic pathways is a key determinant for chemoresistance in which gelsolin (GSN) is critically involved. We analyzed the association between GSN expression and cisplatin resistance in HNC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
